Patents by Inventor Howard Hait

Howard Hait has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
    Patent number: 8288342
    Abstract: The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
    Type: Grant
    Filed: October 12, 2009
    Date of Patent: October 16, 2012
    Assignee: Teva Women's Health, Inc.
    Inventors: Salah U. Ahmed, Sundeep Sethia, Kathleen Reape, Howard Hait, Carole S. Ben-Maimon
  • METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION
    Publication number: 20110124611
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: October 26, 2010
    Publication date: May 26, 2011
    Applicant: TEVA WOMEN'S HEALTH, INC.
    Inventors: ROBERT G. BELL, CAROLE S. BEN-MAIMON, BEATA ISKOLD, LANCE J. BRONNENKANT, HOWARD HAIT, KATHLEEN Z. REAPE
  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Patent number: 7855190
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 21, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole S. Ben-Maimon, Beata Iskold, Lance J. Bronnenkant, Howard Hait, Kathleen Z. Reape
  • Methods for Treating Vasomotor Symptoms in Castrated Prostatic Cancer Patients with Low Dose Cyproterone Acetate
    Publication number: 20100260860
    Abstract: The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
    Type: Application
    Filed: October 12, 2009
    Publication date: October 14, 2010
    Inventors: Salah U. AHMED, Sundeep Sethia, Kathleen Reape, Howard Hait, Carole S. Ben-Maimon
  • Methods of hormonal treatment utilizing extended cycle contraceptive regimens
    Patent number: 7772219
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: August 10, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant
  • Methods of Step-Down Hormone Treatment
    Publication number: 20090163454
    Abstract: The present invention relates to methods of step-down hormone treatment in which an estrogen and progestin combination regimen is administered for one or more cycles prior to administration of a lower dose hormone regimen containing a lower daily dosage amount of estrogen and/or progestin.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 25, 2009
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Howard Hait, Kathleen Reape
  • Vaginal cream compositions, kits thereof and methods of using thereof
    Publication number: 20080070882
    Abstract: The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
    Type: Application
    Filed: August 17, 2007
    Publication date: March 20, 2008
    Inventors: Salah Ahmed, Charles Diliberti, Carole Ben-Maimon, Howard Hait
  • Vaginal cream compositions, kits thereof and methods of using thereof
    Publication number: 20060040904
    Abstract: The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
    Type: Application
    Filed: August 17, 2004
    Publication date: February 23, 2006
    Inventors: Salah Ahmed, Charles Diliberti, Carole Ben-Maimon, Howard Hait
  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Publication number: 20050143359
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: July 16, 2004
    Publication date: June 30, 2005
    Inventors: Robert Bell, Carole Ben-Maimon, Beata Iskold, Lance Bronnenkant, Howard Hait, Kathleen Reape
  • Methods of hormonal treatment utilizing extended cycle contraceptive regimens
    Publication number: 20040220152
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: May 3, 2004
    Publication date: November 4, 2004
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant